HIV Conference Coverage

HIV Conference Coverage

HIV RESEARCH: 10 Top Studies Whose Impact Will Last Well Beyond CROI 2013

HIV TREATMENT & HEALTH ISSUES: Expert Panel: HIV Drugs in Development, Antiretroviral Strategy and Treatment as Prevention (Video)

SEARCH FOR THE CURE: Functional Cure for HIV-Infected Infant After Very Early Treatment

HIV TREATMENT & PATIENT CARE: New Research Explores Second-Line Therapy Options

More from IDWeek 2012 >>

DRUGS IN DEVELOPMENT: Once-Weekly and Once-Monthly HIV Meds in the Pipeline: Studies From ICAAC 2012

HIV/AIDS TREATMENT STRATEGIES: Stribild (a.k.a. "Quad") May Slightly Outperform Other Popular First-Line Options, Study Finds

HIV TREATMENT & HEALTH ISSUES: Ongoing HIV Infection Could Explain Low CD4 Counts Despite Undetectable Viral Loads, Study Suggests

HIV/AIDS TREATMENT STRATEGIES: Stribild (a.k.a. "Quad") Performs Well for People Over 50, Study Finds

More from ICAAC 2012 >>

FEATURED COVERAGE

COMING SOON

TheBodyPRO.com Covers the 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013), June 30 - July 3

TheBodyPRO.com is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. TheBodyPRO.com and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of TheBodyPRO.com's homepage, topic pages, page designs and HTML code. General Disclaimer: TheBodyPRO.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBodyPRO.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.